A high-quality, open access journal edited by experts in diabetes and endocrinology. Published by BMJ in partnership with the American Diabetes Association.

Hoboken, NJ
Joined October 2013
We鈥檙e making an impact together. Take a look at our latest journal metrics 馃搳 Impact Factor and top-cited content. bit.ly/4bl7VCm Behind every published finding is a shared purpose: advancing medical knowledge to improve patient health. #JournalMetrics #BMJGroupImpact
1
471
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry Learn more 馃憠 bit.ly/3LIk3UC
234
Association of genetic variation with age at diagnosis of type 1 diabetes 馃憞 Read the full findings here bit.ly/49OK90l
1
90
Clustering patterns in Finnish type 1 diabetes (T1D) patients: a nationwide register-based study Learn more 馃憞 bit.ly/4qBsG1V
84
Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes (T2D) Learn more: 馃憠 bit.ly/49k3FmN
1
63
Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin Learn more 馃憞 bit.ly/4qeQWXc
47
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity Follow this link to review the latest guidance from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults 馃憠 bit.ly/4teuznj
76
National access to renal transplantation and post-transplant survival among patients with diabetes: deceased and living donor outcomes Learn more 馃憞
70
Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study) 馃憖 Read the full paper here: bit.ly/3Z0zaM8
2
144
Zero Dollar Drug Copay program improves antidiabetic medication adherence and medication use patterns among Blue Cross and Blue Shield of Louisiana members with diabetes in Louisiana Learn more 馃憞 bit.ly/4rggfZT
72
Association of genetic variation with age at diagnosis of type 1 diabetes 馃憞 Read the full findings here bit.ly/49OK90l
1
69
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry Learn more 馃憠 bit.ly/3LIk3UC
1
59
Food insecurity patterns and mental health among youth and young adults with diabetes Learn more 馃憞 bit.ly/4ppCTgY
22
Identification and characterization of novel PAX4 variants in patients with suspected MODY9 Read more: bit.ly/3Z5vatD
1
57
Metal mixture inflammatory index and diabetes risk in US adults: a cross-sectional analysis of NHANES 1999-2020 and development of a LASSO-based prediction model Learn more 馃憠 bit.ly/3YZl6Cx
1
2
47
Trends in delaying and forgoing medical care due to cost and the association with insurance status among US adults with diabetes, 2009-2023 馃憖 bit.ly/49IlGuv
36
HOT OFF THE PRESS! Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity Follow this link to review the brand new recommendations from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults 馃憠
1
77
Clustering patterns in Finnish type 1 diabetes (T1D) patients: a nationwide register-based study Learn more 馃憞 bit.ly/4qBsG1V
44
Identifying interhospital variation in hyperosmolar hyperglycemic syndrome (HHS) care: development and outcomes of the DEKODE HHS model 馃憞 Learn more bit.ly/4pDMn9g
67
Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists in heart failure patients with type 2 diabetes (T2D) Learn more 馃憠 bit.ly/489r60P
48